Dynavax Technologies Competitors and Similar CompaniesClear all
Dynavax Technologies's competitors and similar companies include Chiesi Group, YiChang HEC ChangJiang Pharmaceutical and UCB.
 Dynavax Technologies Dynavax Technologies Corporation is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious, autoimmune and inflammatory diseases, and the treatment of cancer. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1996 | Founding Date 1935 | Founding Date 2001 | Founding Date 1928 |
Type | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Emeryville, US HQ Düsseldorf, DE Berkeley, US | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 24946% increase | Employees 5,8541% increase | Employees 4,595 | Employees 9,052 |
Valuation ($) | Valuation ($) 1.5 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $277.2m (FY, 2024) | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ¥3.7b (FY, 2024) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥533.6m (FY, 2024) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥3.2b (FY, 2024) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $27.3m (FY, 2024) | Net income N/A | Net income ¥482.7m (FY, 2024) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Chiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyYiChang HEC ChangJiang Pharmaceutical
HQ
Employees
4,595
YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company